Total Payments
$6,946
2024 Payments
$1,459
Companies
39
Transactions
439
Medicare Patients
2,690
Medicare Billing
$170,092

Payment Breakdown by Category

Food & Beverage$6,896 (99.3%)
Education$50.00 (0.7%)

Payments by Nature

Nature of Payment Amount Transactions Share
Food and Beverage $6,896 437 99.3%
Education $50.00 2 0.7%

Top Paying Companies

Company Total Records Latest Year
ABBVIE INC. $964.98 72 $0 (2024)
GlaxoSmithKline, LLC. $896.06 56 $0 (2024)
Novo Nordisk Inc $881.64 63 $0 (2024)
PFIZER INC. $534.01 29 $0 (2024)
Boehringer Ingelheim Pharmaceuticals, Inc. $475.34 30 $0 (2024)
AstraZeneca Pharmaceuticals LP $334.47 21 $0 (2024)
Lilly USA, LLC $319.43 18 $0 (2024)
Amgen Inc. $298.10 18 $0 (2024)
Janssen Pharmaceuticals, Inc $274.82 16 $0 (2024)
Novartis Pharmaceuticals Corporation $206.15 12 $0 (2023)

Payment History by Year

Year Amount Transactions Top Company
2024 $1,459 90 ABBVIE INC. ($299.92)
2023 $1,007 53 GlaxoSmithKline, LLC. ($230.67)
2022 $1,572 94 ABBVIE INC. ($315.29)
2021 $807.61 57 AbbVie Inc. ($299.68)
2020 $421.93 29 Novo Nordisk Inc ($176.73)
2019 $482.99 37 Novo Nordisk Inc ($147.50)
2018 $1,042 68 PFIZER INC. ($208.67)
2017 $153.94 11 Novo Nordisk Inc ($36.42)

All Payment Transactions

439 individual payment records from CMS Open Payments — Page 3 of 18

Date Company Product Nature Form Amount Type
07/18/2024 Abbott Laboratories FREESTYLE LIBRE 3 (Device) Food and Beverage In-kind items and services $19.56 General
Category: Diabetes Care
07/18/2024 GlaxoSmithKline, LLC. TRELEGY ELLIPTA (Drug) Food and Beverage In-kind items and services $18.98 General
Category: RESPIRATORY
07/09/2024 ABBVIE INC. QULIPTA (Drug) Food and Beverage In-kind items and services $30.83 General
Category: NEUROSCIENCE
06/25/2024 Amgen Inc. Otezla (Drug), Repatha Food and Beverage In-kind items and services $13.87 General
Category: Inflammation
06/24/2024 ABBVIE INC. UBRELVY (Drug), QULIPTA Food and Beverage In-kind items and services $6.45 General
Category: NEUROSCIENCE
06/12/2024 Lilly USA, LLC MOUNJARO (Drug) Food and Beverage In-kind items and services $21.49 General
Category: Diabetes
06/05/2024 SANOFI-AVENTIS U.S. LLC TZIELD (Biological) Food and Beverage In-kind items and services $13.79 General
Category: Endocrine & Metabolic Diseases
05/24/2024 AstraZeneca Pharmaceuticals LP Food and Beverage In-kind items and services $13.49 General
05/23/2024 GlaxoSmithKline, LLC. TRELEGY ELLIPTA (Drug) Food and Beverage In-kind items and services $10.60 General
Category: RESPIRATORY
05/21/2024 ABBVIE INC. UBRELVY (Drug), QULIPTA Food and Beverage In-kind items and services $7.55 General
Category: NEUROSCIENCE
05/17/2024 Bayer Healthcare Pharmaceuticals Inc. Kerendia (Drug) Food and Beverage In-kind items and services $13.68 General
Category: Cardio-renal
05/07/2024 ABBVIE INC. QULIPTA (Drug), UBRELVY Food and Beverage In-kind items and services $6.24 General
Category: NEUROSCIENCE
05/03/2024 AstraZeneca Pharmaceuticals LP FARXIGA (Drug) Food and Beverage In-kind items and services $34.58 General
Category: Cardiovascular and Metabolism
05/01/2024 Lilly USA, LLC ZEPBOUND (Drug) Food and Beverage In-kind items and services $24.61 General
Category: Obesity
05/01/2024 ABBVIE INC. UBRELVY (Drug), QULIPTA Food and Beverage In-kind items and services $4.46 General
Category: NEUROSCIENCE
04/30/2024 PFIZER INC. NURTEC ODT (Drug), ZAVZPRET Food and Beverage In-kind items and services $14.04 General
Category: PAIN
04/24/2024 Lilly USA, LLC MOUNJARO (Drug), ZEPBOUND Food and Beverage In-kind items and services $16.65 General
Category: Diabetes
04/16/2024 GlaxoSmithKline, LLC. TRELEGY ELLIPTA (Drug) Food and Beverage In-kind items and services $20.81 General
Category: RESPIRATORY
04/11/2024 Novo Nordisk Inc Ozempic (Drug) Food and Beverage In-kind items and services $19.04 General
Category: Diabetes
04/11/2024 ABBVIE INC. UBRELVY (Drug), QULIPTA Food and Beverage In-kind items and services $7.49 General
Category: NEUROSCIENCE
04/10/2024 AstraZeneca Pharmaceuticals LP AIRSUPRA (Drug) Food and Beverage In-kind items and services $14.85 General
Category: Respiratory
04/03/2024 Lilly USA, LLC MOUNJARO (Drug), ZEPBOUND Food and Beverage In-kind items and services $14.13 General
Category: Diabetes
03/20/2024 Lilly USA, LLC ZEPBOUND (Drug) Food and Beverage In-kind items and services $17.20 General
Category: Obesity
03/14/2024 GlaxoSmithKline, LLC. TRELEGY ELLIPTA (Drug) Food and Beverage In-kind items and services $16.15 General
Category: RESPIRATORY
03/14/2024 ABBVIE INC. VRAYLAR (Drug) Food and Beverage In-kind items and services $6.53 General
Category: NEUROSCIENCE

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 13 736 1,110 $187,483 $43,418
2022 15 751 1,071 $164,899 $38,505
2021 14 583 678 $95,058 $45,626
2020 13 620 905 $111,526 $42,544
Total Patients
2,690
Total Services
3,764
Medicare Billing
$170,092
Procedure Codes
55

All Medicare Procedures & Services

55 procedure records from CMS Medicare Utilization — Page 2 of 3

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
87880 Detection test by immunoassay with direct visual observation for streptococcus, group a (strep) Office 2022 15 16 $496.00 $259.85 52.4%
81003 Automated urinalysis test Office 2022 64 72 $504.00 $159.52 31.7%
36415 Insertion of needle into vein for collection of blood sample Office 2022 31 33 $495.00 $98.10 19.8%
99214 Established patient outpatient visit, total time 30-39 minutes Office 2021 119 189 $39,690 $18,081 45.6%
99215 Established patient outpatient visit, total time 40-54 minutes Office 2021 59 72 $20,376 $9,797 48.1%
G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit Office 2021 63 63 $14,301 $8,302 58.1%
90694 Influenza virus vaccine, quadrivalent (aiiv4), inactivated, adjuvanted, preservative free, for injection into muscle, 0.5 ml dosage Office 2021 37 37 $2,923 $2,458 84.1%
0002A Adm sarscov2 30mcg/0.3ml 2nd Office 2021 44 44 $4,664 $1,708 36.6%
99443 Physician telephone patient service, 21-30 minutes of medical discussion Office 2021 14 14 $3,066 $1,254 40.9%
0003A Fee covid-19 vac 1 booster Office 2021 26 26 $2,210 $1,009 45.7%
G0008 Administration of influenza virus vaccine Office 2021 58 58 $2,900 $958.16 33.0%
90662 Vaccine for influenza for injection into muscle, split virus, preservation free Office 2021 19 19 $760.00 $760.00 100.0%
0004A Fee covid-19 vac 1 res Office 2021 14 14 $1,190 $543.34 45.7%
93000 Routine ekg using at least 12 leads including interpretation and report Office 2021 32 32 $1,056 $293.50 27.8%
G0009 Administration of pneumococcal vaccine Office 2021 12 12 $780.00 $198.24 25.4%
36415 Insertion of needle into vein for collection of blood sample Office 2021 49 57 $855.00 $171.00 20.0%
81003 Automated urinalysis test Office 2021 37 41 $287.00 $92.25 32.1%
99214 Established patient office or other outpatient, visit typically 25 minutes Office 2020 172 380 $79,800 $27,661 34.7%
G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit Office 2020 36 36 $8,172 $4,142 50.7%
99213 Established patient office or other outpatient visit, typically 15 minutes Office 2020 28 35 $4,970 $1,923 38.7%
90662 Vaccine for influenza for injection into muscle Office 2020 45 45 $1,800 $1,799 100.0%
90732 Vaccine for pneumococcal polysaccharide for injection beneath the skin or into muscle, patient 2 years or older Office 2020 13 13 $2,106 $1,535 72.9%
99215 Established patient office or other outpatient, visit typically 40 minutes Office 2020 12 12 $3,396 $1,278 37.6%
99442 Physician telephone patient service, 11-20 minutes of medical discussion Office 2020 20 22 $2,515 $1,214 48.3%
G0008 Administration of influenza virus vaccine Office 2020 57 57 $1,750 $927.06 53.0%

About Dr. Iram Mall, M.B.B.S

Dr. Iram Mall, M.B.B.S is a Student in an Organized Health Care Education/Training Program healthcare provider based in Albany, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/17/2014. The National Provider Identifier (NPI) number assigned to this provider is 1538573514.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Iram Mall, M.B.B.S has received a total of $6,946 in payments from pharmaceutical and medical device companies, with $1,459 received in 2024. These payments were reported across 439 transactions from 39 companies. The most common payment nature is "Food and Beverage" ($6,896).

As a Medicare-enrolled provider, Mall has provided services to 2,690 Medicare beneficiaries, totaling 3,764 services with total Medicare billing of $170,092. Data is available for 4 years (2020–2023), covering 55 distinct procedure/service records.

Practice Information

Products in Payments

  • TRELEGY ELLIPTA (Drug) $698.91
  • UBRELVY (Drug) $521.56
  • Saxenda (Drug) $375.49
  • JARDIANCE (Drug) $351.20
  • QULIPTA (Drug) $340.14
  • Ozempic (Drug) $333.71
  • NURTEC ODT (Drug) $293.07
  • ELIQUIS (Drug) $226.98
  • FARXIGA (Drug) $219.58
  • XARELTO (Drug) $198.97
  • MOUNJARO (Drug) $146.73
  • JANUVIA (Drug) $140.93
  • VRAYLAR (Drug) $137.50
  • ZENPEP (Drug) $137.20
  • Otezla (Drug) $134.01
  • XIFAXAN (Drug) $131.99
  • LEQVIO (Drug) $125.84
  • SHINGRIX (Biological) $116.89
  • CHANTIX (Drug) $115.55
  • EUCRISA (Drug) $110.53

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Student in an Organized Health Care Education/Training Program Doctors in Albany